Reltecimod TFA

• Target :

  Immunology/Inflammation related|||Antibacterial

• Related Pathways :

  Microbiology/Virology|||Immunology/Inflammation

• Purity :

  0.9978

• Bioactivity :

  Reltecimod TFA (AB-103 TFA) is a CD28 (T-lymphocyte receptor) mimetic that acts as a CD28 antagonist, inhibiting the stimulation of t-cells by a range of bacterial pathogens thereby attenuating acute inflammation for the treatment of necrotizing soft tissue infections (NSTI) .

• Smiles :

  [H]N[C@@H](C)C(N[C@H](C(N1CCC[C@H]1C(N[C@@H](CCSC)C(N[C@H](C(N[C@H](C(N[C@@H](C)C(N[C@@H](CC2=CC=C(C=C2)O)C(N[C@@H](CC(O)=O)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O)C(C)C)=O)CC(C)C)=O)=O)=O)CO)=O.OC(C(F)(F)F)=O

• Molecular Formula :

  C48H73F3N10O17S

• Molecular Weight :

  1151.21

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C